Thyrocare Technologies informs about appointment of chief commercial officer

23 Feb 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Thyrocare Technologies has informed that, Nitin Chugh has been appointed as Chief Commercial Officer of the Company, being part of the Senior Management of the Company with effect from February 22, 2024. Further, the details/disclosures required under Regulation 30 of the SEBI Listing Regulations, read the SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are enclosed as Annexure -A.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

460.15 7.55 (1.67%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7154.70
Max Healthcare Inst 1074.45
Narayana Hrudayalay 1859.95
Aster DM Healthcare 617.30
Global Health 1173.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×